NEUROGENE INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.35 USD | -1.40% |
|
+0.32% | +92.72% |
| Jun. 03 | Neurogene's Gene Therapy For Rett Syndrome Picked For FDA Pilot Program | MT |
| Jun. 03 | Neurogene Inc. Announces NGN-401 Gene Therapy for Rett Syndrome Selected by FDA for Start Pilot Program | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Neutral |
| Resistance | 37.88 | 50.90 | 50.90 |
| Spread/Res. | -1.40% | -26.62% | -26.62% |
| Spread/Supp. | +9.82% | +28.17% | +26.78% |
| Support | 34.01 | 29.14 | 29.46 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- NGNE Stock
- Charts Neurogene Inc.
